Lakshi Aldredge, MSN, ANP-BC, DCNP

Alexa Hetzel, MA, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, PA, share practice pearls and clinical management tips for the care of pediatric patients with atopic dermatitis.

Experts in dermatology hypothesize about the next round of treatment disruptions and their hopes for the future of atopic dermatitis management.

Alexa Hetzel, MA, PA-C, and Lakshi Aldredge, MSN, ANP-BC, DCNP, provide insight into emerging therapies and ongoing investigations in the management of pediatric atopic dermatitis.

Experts in dermatology comment on the impact of treatment response time on pediatric atopic dermatitis burden.

Alexa Hetzel, MA, PA-C; Matthew Brunner, PA; and Lakshi Aldredge, MSN, ANP-BC, DCNP, share their real-world utilization experiences with dupilumab in pediatric patients with atopic dermatitis.

Lakshi Aldredge, MSN, ANP-BC, DCNP, reviews the evolution of the treatment landscape for pediatric patients with atopic dermatitis; highlighting recent advances.

A panel of experts in dermatology share their tips and tricks when utilizing topical therapies for pediatric patients with atopic dermatitis.

Matthew Brunner, PA, shares his advice for engaging pediatric patients with atopic dermatitis in their treatment and disease care, while Lakshi Aldredge, MSN, ANP-BC, DCNP, discusses her treatment protocols.

A panel of experts in dermatology management provide insight into the role of multidisciplinary care for pediatric patients with atopic dermatitis.

Melodie Young, NP; Alexa Hetzel, MA, PA-C; and Matthew Brunner, PA, discuss their approach to a clinical examination of patients with pediatric atopic dermatitis.

Experts in dermatology describe their clinical experiences of atopic dermatitis presentation in their patients, focusing on the heterogeneity across age groups and races.

Lakshi Aldredge, MSN, ANP-BC, DCNP, provides an overview of the prevalence of atopic dermatitis across age groups and discusses the impact of itch on these patients.

Melodie Young, NP; Alexa Hetzel, MA, PA-C; and Matthew Brunner, PA, provide insight into pediatric atopic dermatitis, highlighting disease recurrence and symptomology.

Matthew Brunner, MHS, PA-C, DFAAPA, highlights the most anticipated developments in the field of treating patients with plaque psoriasis.

Stratification of patients for the treatment of plaque psoriasis based on comorbidities and prior biologic experience.

Advanced practice providers discuss scenarios in which they would consider switching between therapies when treating patients with plaque psoriasis.

Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, MHS, PA-C, DFAAPA share their personal experiences with using IL-23 inhibitors in treating patients with plaque psoriasis.

Mechanism of action and dosing of IL-23 inhibitors use to treat plaque psoriasis as explained by advanced practice providers.

IL-17 inhibitors and IL-12/23 inhibitors used in the treatment of plaque psoriasis.

Matthew Brunner, MHS, PA-C, DFAAPA, and Lakshi Aldredge, MSN, ANP-BC, DCNP, share their experiences with tumor necrosis factor (TNF) inhibitors in treating plaque psoriasis.

Matthew Brunner, MHS, PA-C, DFAAPA, and Lakshi Aldredge, MSN, ANP-BC, DCNP, discuss factors leading to transition from topical agents to oral systemic therapies for plaque psoriasis.

Matthew Brunner, MHS, PA-C, DFAAPA, and Lakshi Aldredge, MSN, ANP-BC, DCNP, review use of nonbiologic oral systemic agents (eg, apremilast, methotrexate, acitretin) in the management of plaque psoriasis.

Matthew Brunner, MHS, PA-C, DFAAPA, and Lakshi Aldredge, MSN, ANP-BC, DCNP, discuss the current role of topical medications as the standard of care for initial therapy in plaque psoriasis.

Lifestyle modification and counseling to help manage flare-ups resulting from triggers for plaque psoriasis.

Diagnosis and management of plaque psoriasis as discussed by advanced practice providers.

Advanced practice providers share their perspectives on assessing and grading the disease severity of plaque psoriasis.

The clinical and psychological impact of plaque psoriasis on a patient’s overall well-being.